David Barrett - Assembly Biosciences Insider

ASMB -- USA Stock  

USD 34.76  1.34  3.71%

Mr. David J. Barrett CPA, is Chief Financial Officer, Chief Operating Officer of Company. From April 2006 to September 2009, Mr. Barrett served as Chief Financial Officer of NeuroHitech, Inc., a public company focused on developing, marketing and distributing branded and generic pharmaceutical products. From September 2003 to April 2006, Mr. Barrett was the Chief Financial OfficerVice President of Finance of Overture Asset Managers and Overture Financial Services, which, at the time, was a startup asset management firm that assembled investment products and platforms to distribute turnkey and unbundled investment solutions to financial intermediaries and institutional investors. From July 1999 to September 2003, Mr. Barrett was employed as a Manager at Deloitte Touche, LLP. Mr. Barrett also is a director of Coronado Biosciences, Inc., a biopharmaceutical Company
Age: 38  COO Since 2015      
317-210-9311  http://www.assemblybio.com
Barrett received his B.S. in Accounting and Economics and his M.S. in Accounting from the University of Florida. He is a certified public accountant.

David Barrett Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (32.32) % which means that it has lost $32.32 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (80.11) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Found 2 records

COO Since

Daniel BrennanEdge Therapeutics
Michael ShermanEndocyte

Entity Summary

Assembly Biosciences, Inc. operates as a clinical stage biotechnology company. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in Carmel, Indiana. Assembly Biosciences operates under Biotechnology classification in USA and traded on Nasdaq Capital Markets. It employs 89 people.Assembly Biosciences (ASMB) is traded on BATS Exchange in USA. It is located in NEW YORK U.S.A and employs 89 people. Assembly Biosciences was previously known as ASSEMBLY BIOSCIENCES INC and was traded on BATS Exchange under the symbol VTUS. Assembly Biosciences is listed under Pharmaceutical Products category by Fama And French industry classification.

Assembly Biosciences Leadership Team

Uri Lopatin, Vice President - Research & Development, Chief Medical Officer
Helen Kim, Independent Director
Myron Holubiak, Independent Director
Lee Arnold, Chief Scientific Officer
Jacqueline Papkoff, Senior Vice President Chief Scientific Officer Microbiome
Anthony Altig, Independent Director
Richard Colonno, Chief Scientific Officer
Graham Cooper, CFO, COO and Principal Financial Officer and Principal Accounting Officer
William Ringo, Non-Executive Chairman of the Board
Susan Mahony, Director
Richard DiMarchi, Director
Miguel Barbosa, Chief Scientific Officer, Head of Microbiome Program
Thomas Rollins, Chief Development Officer
Mark Auerbach, Independent Director
Derek Small, Co-Founder, CEO and President and Director
Alan Lewis, Director
David Barrett, CFO, COO

Stock Performance Indicators

Did you try this?

Run Bollinger Bands Now


Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
All  Next Launch Bollinger Bands

Assembly Biosciences Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Assembly Biosciences and China Cord Blood. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.
Search macroaxis.com